ETR:AFX - Carl Zeiss Meditec Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
€80.55 0.00 (0.00 %)
(As of 04/23/2019 02:40 AM ET)
Previous Close€80.55
Today's Range€79.70 - €80.85
52-Week Range€53.75 - €84.55
Volume139,210 shs
Average Volume94,405 shs
Market Capitalization$7.20 billion
P/E Ratio56.97
Dividend Yield0.74%
BetaN/A
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; and products for surgical treatment of tumors or vascular diseases, such as aneurysms. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Receive AFX News and Ratings via Email

Sign-up to receive the latest news and ratings for AFX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-3641-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.31 billion
Cash Flow€0.09 per share
Book Value€14.46 per share

Profitability

Miscellaneous

Employees3,050
Market Cap$7.20 billion
Next Earnings Date5/6/2019 (Estimated)
OptionableNot Optionable

Carl Zeiss Meditec (ETR:AFX) Frequently Asked Questions

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

When is Carl Zeiss Meditec's next earnings date?

Carl Zeiss Meditec is scheduled to release their next quarterly earnings announcement on Monday, May 6th 2019. View Earnings Estimates for Carl Zeiss Meditec.

What price target have analysts set for AFX?

9 brokerages have issued 1 year price targets for Carl Zeiss Meditec's shares. Their forecasts range from €58.00 to €92.50. On average, they expect Carl Zeiss Meditec's share price to reach €74.75 in the next year. This suggests that the stock has a possible downside of 7.2%. View Analyst Price Targets for Carl Zeiss Meditec.

What is the consensus analysts' recommendation for Carl Zeiss Meditec?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 2 sell ratings, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carl Zeiss Meditec.

Has Carl Zeiss Meditec been receiving favorable news coverage?

Headlines about AFX stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Carl Zeiss Meditec earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an impact on the stock's share price in the next few days.

Who are some of Carl Zeiss Meditec's key competitors?

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), Adaptimmune Therapeutics (ADAP), Booking (BKNG), Ocular Therapeutix (OCUL), QuinStreet (QNST), Rigel Pharmaceuticals (RIGL), Bemis (BMS), Fresenius Medical Care AG & Co. (FMS), Resideo Technologies (REZI) and UnitedHealth Group (UNH).

Who are Carl Zeiss Meditec's key executives?

Carl Zeiss Meditec's management team includes the folowing people:
  • Dr. Ludwin Monz, Pres, CEO & Chairman of Management Board (Age 56)
  • Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 54)
  • Mr. Jan Willem de Cler, Head of Surgical Ophthalmology & Member of Management Board
  • Mr. Sebastian Frericks, Director of Investor Relations
  • Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit

What is Carl Zeiss Meditec's stock price today?

One share of AFX stock can currently be purchased for approximately €80.55.

How big of a company is Carl Zeiss Meditec?

Carl Zeiss Meditec has a market capitalization of $7.20 billion and generates $1.31 billion in revenue each year. Carl Zeiss Meditec employs 3,050 workers across the globe.

What is Carl Zeiss Meditec's official website?

The official website for Carl Zeiss Meditec is https://www.zeiss.com/meditec-ag/home.html.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.


MarketBeat Community Rating for Carl Zeiss Meditec (ETR AFX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  163 (Vote Outperform)
Underperform Votes:  168 (Vote Underperform)
Total Votes:  331
MarketBeat's community ratings are surveys of what our community members think about Carl Zeiss Meditec and other stocks. Vote "Outperform" if you believe AFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel